Kamada (Kamada) Days Payable

: 77.94 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

Kamada's average Accounts Payable for the three months ended in Dec. 2023 was $18.8 Mil. Kamada's Cost of Goods Sold for the three months ended in Dec. 2023 was $22.0 Mil. Hence, Kamada's Days Payable for the three months ended in Dec. 2023 was 77.94.

The historical rank and industry rank for Kamada's Days Payable or its related term are showing as below:

KMDA' s Days Payable Range Over the Past 10 Years
Min: 87.19 Med: 100.92 Max: 128.14
Current: 104.61

During the past 13 years, Kamada's highest Days Payable was 128.14. The lowest was 87.19. And the median was 100.92.

KMDA's Days Payable is ranked better than
60.16% of 979 companies
in the Drug Manufacturers industry
Industry Median: 86.82 vs KMDA: 104.61

Kamada's Days Payable declined from Dec. 2022 (96.15) to Dec. 2023 (77.94). It may suggest that Kamada accelerated paying its suppliers.

Kamada Days Payable Historical Data

The historical data trend for Kamada's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kamada Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

99.24

87.19

102.59

128.14

121.04

Kamada Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable																96.15	142.95	107.44	80.44	77.94

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kamada's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kamada Days Payable Distribution

For the Drug Manufacturers industry and Healthcare sector, Kamada's Days Payable distribution charts can be found below:

* The bar in red indicates where Kamada's Days Payable falls into.

Kamada Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Kamada's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (32.917	+	24.804)	/	2 )	/	87.029	*	365
=	28.8605					/	87.029	*	365
=	121.04

Kamada's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (12.812	+	24.804)	/	2 )	/	22.02	*	365 / 4
=	18.808					/	22.02	*	365 / 4
=	77.94

Kamada Days Payable Related Terms

Thank you for viewing the detailed overview of Kamada's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Kamada (Kamada) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kamada Ltd (NAS:KMDA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

KMDA:Israel

Address

2 Holzman Street, P.O. Box 4081, Science Park, Rehovot, ISR, 7670402

Website

https://www.kamada.com

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.